In today’s recent session, 754,408 shares of the Salarius Pharmaceuticals, Inc.(NASDAQ:SLRX) have been traded, and its beta is 1.66. Most recently the company’s share price was $1.45, and it changed around $0.05 or 0.04% from the last close, which brings the market valuation of the company to $63.97 Million. SLRX at last check was trading at a discount to its 52-week high of $3.5, offering almost -141.38% off that amount. The share price’s 52-week low was $0.56, which indicates that the recent value has risen by an impressive 61.38% since then. We note from Salarius Pharmaceuticals, Inc.’s average daily trading volume that its 10-day average is 567.3 Million shares, with the 3-month average coming to 2.78 Million.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Salarius Pharmaceuticals, Inc. stock received a consensus recommendation rating of Buy, based on a mean score of 1.5. If we narrow it down even further, the data shows that none out of 2 analysts rate the stock as a Sell; another but none rate it as Overweight. Among the rest, no body recommended SLRX as a Hold, whereas 2 deemed it a Buy, and no one rated it as Underweight. Salarius Pharmaceuticals, Inc. is expected to report earnings per share of -$0.05 for the current quarter.

Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX): Trading Information Today

Instantly SLRX has been showing a green trend so far today with a performance of 3.57% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of $1.55 on Monday, Apr 05 increased the stock’s daily price by 5.81%. The company’s shares are currently up 0.6% year-to-date, but still up 0.0209 over the last five days. On the other hand, Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) is 0.14% up in the 30-day period. We can see from the shorts that 1.11 Million shares have been sold at a short interest cover period of 0.4 day(s).

The consensus price target as assigned by Wall Street analysts is $4.4, which translates to bears needing to increase their stock price by 203.45% from its current value. Analyst projections state that SLRX is forecast to be at a low of $3.8 and a high of $5. In order for the stock price to hit the forecast high, the stock would need to surge +244.83% from its current level, while the stock would need to crash 162.07% from its current level to reach the projected low.

Salarius Pharmaceuticals, Inc. (SLRX) projections and forecasts

Salarius Pharmaceuticals, Inc. share prices are not performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen +72.01 percent over the past six months and at a -56% annual growth rate that is well below the industry average of 17.2%. Moreover, analysts have decided to roll up on their fiscal year 2021 revenue estimates. The rating firms predict that it will gain +77.3% in revenue this quarter, and will report an increase of 61.5% in the next quarter. The year-over-year growth rate is expected to be 6.1%, up from the previous year.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 60.5%. Salarius Pharmaceuticals, Inc. earnings are expected to increase by 76.6% in 2021, but the outlook is negative 0% per year for the next five years.

Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX)’s Biggest Investors

Upon looking at major shareholders, it appears that insiders hold 2.32% of Salarius Pharmaceuticals, Inc. shares, and 13.99% of them are in the hands of institutional investors. The stock currently has a share float of 14.32%. Salarius Pharmaceuticals, Inc. stock is held by 29 institutions, with Sio Capital Management, LLC being the largest institutional investor. By Dec 30, 2020, it held 3.7% of the shares, which is about 1.66 Million shares worth $1.51 Million.


A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


AIGH Capital Management LLC, with 3.37% or 1.51 Million shares worth $1.37 Million as of Dec 30, 2020, holds the second largest percentage of outstanding shares.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Fidelity Extended Market Index Fund and Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Feb 27, 2021. The former held 91779 shares worth $165.2 Thousand, making up 0.21% of all outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held roughly 52.22 Thousand shares worth around $47.52 Thousand, which represents about 0.12% of the total shares outstanding.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

LEAVE A REPLY

Please enter your comment!
Please enter your name here